Immune response to intradermally administrated Ixiaro in healthy adults: a randomized study
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2016
At a glance
- Drugs IC 51 (Primary) ; IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 16 Apr 2016 Planned number of patients changed from 180 to 240.
- 16 Apr 2016 Phase of the trial is changed from phase II to phase IV as per European Clinical Trials Database record.
- 08 Dec 2015 New trial record